Some effects of caffeine and aminophylline on the turnover of catecholamines in the brain.
D000628:Aminophylline / Q000494:pharmacology*; D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry; D002110:Caffeine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D002395:Catecholamines / Q000378:metabolism*; D004298:Dopamine / Q000032:analysis; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D005260:Female; D007093:Imidazoles / Q000494:pharmacology; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000032:analysis; D014316:Tritium; D014443:Tyrosine / Q000494:pharmacology; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors; D014970:Xanthines / Q000494:pharmacology
D000814:Aniline Compounds; D002395:Catecholamines; D007093:Imidazoles; D008996:Monoamine Oxidase Inhibitors; D014970:Xanthines; D014316:Tritium; D000628:Aminophylline; D002110:Caffeine; D014443:Tyrosine; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D001058:Apomorphine; D004298:Dopamine; D009638:Norepinephrine